Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05792436
Other study ID # SPROUT-2
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 27, 2023
Est. completion date February 1, 2025

Study information

Verified date February 2024
Source Seoul National University Hospital
Contact Karam Nam, MD
Phone 82-2-2072-0643
Email karamnam@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hypotension is common during surgery and about one-third of hypotension occur during the period from anesthesia induction to skin incision. Therefore, monitoring blood pressure during this period is crucial. Two methods are used for measuring blood pressure during surgery: the intermittent measurement method (oscillometric method) and the continuous measurement method (arterial catheterization method). The latter is frequently used in surgical patients who require meticulous hemodynamic management, although there is no clearly defined indication for its use. Despite the benefits of arterial catheterization, it is often delayed after induction of general anesthesia, and blood pressure is monitored intermittently using the oscillometric method. A recent study showed that continuous arterial pressure monitoring using arterial catheterization method during the induction of general anesthesia reduced hypotension significantly compared to 2.5-min interval intermittent arterial pressure monitoring using oscillometric method. The study was conducted on patients scheduled for continuous arterial pressure monitoring during surgery and the group with continuous arterial pressure monitoring showed significantly lower incidence of hypotension during the first 15 minutes of anesthesia induction. However, measuring blood pressure using the oscillometric method at 1-min interval, rather than 2.5-min interval, may not be significantly inferior to continuous monitoring via arterial catheterization in terms of hypotension occurrence. This study aims to compare hypotension incidence between arterial catheterization method and oscillometric method with 1-min interval during induction of anesthesia in non-cardiac surgery patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 244
Est. completion date February 1, 2025
Est. primary completion date January 1, 2025
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - Adult patients aged 19 or older undergoing scheduled non-cardiac surgery with general anesthesia and continuous invasive arterial blood pressure monitoring via the radial artery Exclusion Criteria: - Arterial access is clinically necessary before induction of anesthesia (e.g., moderate or higher degree of aortic stenosis, moderate or higher degree of heart failure, coronary artery disease requiring revascularization, intracranial aneurysm with a significant risk of rupture, etc.) - Emergency surgery - American Society of Anesthesiologists (ASA) physical status 5 or 6 - Arterial access is required in a different artery other than the radial artery (e.g., the femoral artery) - Electrocardiogram other than sinus rhythm - Refusal to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
1-min interval oscillometric method
Before induction of anesthesia, 20-gauge catheter is inserted to radial artery after local anesthesia with lidocaine, and continuous blood pressure monitoring is started. Anesthesia is induced using propofol, opioids (fentanyl or remifentanil), and neuromuscular relaxants (rocuronium, cisatracurium, or vecuronium). For maintenance of anesthesia, propofol infusion or inhalation anesthetics (sevoflurane or desflurane) are used. From the start of anesthesia induction to 15 minutes after, arterial blood pressure is monitored at 1-min interval using oscillometric method. The display of continuous arterial pressure on the anesthesia monitor is turned off during the 15-min study period.
arterial catheterization method
During the same time window for 1-min interval oscillometric method, arterial blood pressure is monitored using continuous blood pressure monitoring.

Locations

Country Name City State
Korea, Republic of Korea University Guro Hospital Seoul
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary MAP integral The area under the mean arterial pressure (MAP) of 65 mmHg calculated using the MAP recorded every second From the start of anesthesia induction to 15 minutes after
Secondary Area under MAP of 60, 50, 40 mmHg (mmHg·min) calculated using the MAP recorded every second From the start of anesthesia induction to 15 minutes after
Secondary Duration of MAP <65, <60, <50, <40 mmHg (min) calculated using the MAP recorded every second From the start of anesthesia induction to 15 minutes after
Secondary Exposure to MAP <65, <60, <50, and <40 mmHg (binary) calculated using the MAP recorded every second From the start of anesthesia induction to 15 minutes after
Secondary Exposure to continuous MAP <65, <60, <50, <40 mmHg for 1 minute or longer (binary) calculated using the MAP recorded every second From the start of anesthesia induction to 15 minutes after
Secondary Area above MBP of 100, 110, 120, 140 mmHg (mmHg·min) calculated using the MAP recorded every second From the start of anesthesia induction to 15 minutes after
Secondary MAP standard deviation (mmHg) calculated using the MAP recorded every second From the start of anesthesia induction to 15 minutes after
Secondary Use of vasopressor (binary) ephedrine, phenylephrine, norepinephrine (binary) From the start of anesthesia induction to 15 minutes after
Secondary Use of vasopressor (dose) ephedrine (mg), phenylephrine (µg/kg), norepinephrine (µg/kg) From the start of anesthesia induction to 15 minutes after
Secondary Crystalloid (ml) Total amount of crystalloid administered From the start of anesthesia induction to 15 minutes after
See also
  Status Clinical Trial Phase
Recruiting NCT06063798 - Respiratory Effects of Flow-Controlled Ventilation and Jet Ventilation in Patients Undergoing Laryngotracheal Surgery N/A
Not yet recruiting NCT05035069 - Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR Phase 4
Completed NCT03861364 - Hemodynamics During Induction of General Anesthesia With High and Low Propofol Dose. Phase 4
Completed NCT02711280 - The Effect of Anesthetics on Oxidative Stress and Apoptosis Status in Children N/A
Completed NCT01199471 - Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane N/A
Completed NCT00917033 - Tracheal Intubation of Morbidly Obese Patients. GlideScope Versus Direct Laryngoscopy Phase 4
Completed NCT00391885 - Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy Phase 4
Completed NCT00552617 - A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971) Phase 2
Completed NCT03705026 - Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han Population
Completed NCT00552929 - A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Caucasian Participants. Part B (P05974) Phase 2
Completed NCT00475215 - Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017) Phase 3
Completed NCT00298831 - Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023) Phase 3
Recruiting NCT03943745 - EEG Changes During Induction of Propofol Anesthesia
Completed NCT03697642 - Nasopharyngeal Airway Guide Nasogastric Tube Placement N/A
Completed NCT04595591 - Observation of Propofol Titration at Different Speeds N/A
Not yet recruiting NCT05841316 - The ED95 Dose of Sugammadex to Reverse Rocuronium-Induced Deep Neuromuscular Block Back to Shallow Neuromuscular Block
Completed NCT04532502 - Impact of Anesthetic Environment the Sex Ratio of the Children of Female Assistants
Completed NCT03330236 - EEG - Guided Anesthetic Care and Postoperative Delirium N/A
Recruiting NCT06205212 - High-flow Nasal Oxygenation During Preoxygenation and Atelectasis N/A
Completed NCT00379613 - Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942) Phase 2